Stock Information
Recursion Pharmaceuticals Inc (RXRX)
Ticker Symbol: RXRX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,582.19 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.0382
Revenue (TTM): $0.10 M
Dividend Yield: N/A%
ROE: -50.41%
Latest News
-
Jim Cramer: These Utilities Stocks Are 'Oversold,' Fastly 'Back From The Abyss'
Thu, Aug 13, 2026 8:00 AM
-
These Are the Stocks Wall Street Is Betting Against the Most
Wed, Aug 12, 2026 7:30 PM
-
Recursion (RXRX) Q2 2026 Earnings Call Transcript
Wed, Aug 12, 2026 1:59 PM
-
The Biggest IPO of the Year Is Targeted in the Next 60 Days. Why One Unexpected Industry Could Rally Before Then (Hint: It’s Not Tech)
Tue, Aug 11, 2026 6:00 PM
-
Recursion Pharmaceuticals, Inc. (RXRX) Presents at Bank of America SMID Cap Virtual Conference Transcript
Tue, Aug 11, 2026 4:47 PM
-
Recursion Pharmaceuticals: I'm Still Bearish Despite Recent Genentech News
Mon, Aug 10, 2026 7:22 PM
-
Recursion Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation
Sun, Aug 9, 2026 7:17 PM
Key Financials
Financial data not available
